-
29-02-2016, 10:15 AM
#14201
Originally Posted by Balance
Year end window dressing on a grand scale by the institutions stuck with all that lovely underwritten stock at 61 cents.
So :
15% down on their underwritten shares and,
41% down on the 89 cents at beginning of 2015, and
65% down on the $1.47 at beginning of 2014.
NZ market was up 13.5% so under performances was 54.5%.
All in perspective.
Directors and management of PEB need to look closely at how they have mismanaged this company and misspent the tens of millions of new capital entrusted to them (with them contributing nothing in the last capital raising) as 2016 dawns.
Then, PEB may have a good year in 2016 and beyond.
Now watch the underwriters try and suck others into the 'hype'.
-
29-02-2016, 10:44 AM
#14202
PEB top of the leader board - +20% already
“ At the top of every bubble, everyone is convinced it's not yet a bubble.”
-
29-02-2016, 10:59 AM
#14203
Member
Great news.
Also encouraging to see a positive statement about revenue in the press release: "Laboratory through-put and revenue are tracking to the company’s expectations following an active direct sales and marketing program to clinicians and healthcare organisations."
-
29-02-2016, 11:26 AM
#14204
Member
The market will correct itself by the end of the day probably, so I won't be surprised if it drops near the 40c again. We won't see any major moves in the share price until the company starts making profit and reports the actual numbers of tests sold. They have certainly been waiting for the opportune time to list the numbers, to provide actual scale to investors, and so when the US numbers start hiking it should give them the confidence needed. I don't disagree with Balance at the moment that the actual numbers to date, although not known, are likely very underwhelming.
-
29-02-2016, 11:34 AM
#14205
Member
Originally Posted by winner69
PEB top of the leader board - +20% already
Yes but the announcement was "Not Price Sensitive". Seems the share price is "Announcement Sensitive" though
-
29-02-2016, 11:54 AM
#14206
Originally Posted by Bilbo
Yes but the announcement was "Not Price Sensitive". Seems the share price is "Announcement Sensitive" though
PEB management/advisors have it sussed
'Price Sensitive' is bad and share price falls
Not being 'Price Sensitive' leads to speculation and share price rockets
Clever eh
“ At the top of every bubble, everyone is convinced it's not yet a bubble.”
-
29-02-2016, 12:09 PM
#14207
Originally Posted by okane
Great news.
Also encouraging to see a positive statement about revenue in the press release: "Laboratory through-put and revenue are tracking to the company’s expectations following an active direct sales and marketing program to clinicians and healthcare organisations."
PEB will always meet expectations - they change their expectations every quarter.
-
29-02-2016, 12:15 PM
#14208
Originally Posted by Balance
PEB will always meet expectations - they change their expectations every quarter.
Damned if they do and damned if they don't ay Balance? Are you trying to tell us the Vets agreement is actually bad for PEB. If not, is it a surprise the SP has lifted? A healthy cynicism is a good thing when investing, but maybe there is a point when it becomes unhealthy.
-
29-02-2016, 12:18 PM
#14209
Originally Posted by winner69
PEB top of the leader board - +20% already
A repeat of the window washing in December 2015.
-
29-02-2016, 12:19 PM
#14210
Originally Posted by jonu
Damned if they do and damned if they don't ay Balance? Are you trying to tell us the Vets agreement is actually bad for PEB. If not, is it a surprise the SP has lifted? A healthy cynicism is a good thing when investing, but maybe there is a point when it becomes unhealthy.
It is a fact - they change their expectations.
Tags for this Thread
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|
|
Bookmarks